Lipotek Pharmaceuticals Private Limited

Lipotek Pharmaceuticals Private Limited - trading in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
CIN U51909TN2016PTC104180 Incorporated 17 February 2016 ROC Chennai HQ Chennai, Tamil Nadu, India
Active Private Limited Company trading
Revenue · FY 2025
₹36.8 Lakh
▲ 26% YoY
Net loss · FY 2025
₹9,346
Net margin -0.3%
EBITDA · FY 2025
-₹7,470
EBITDA margin -0.2%
Authorised capital
₹3 Lakh
Registered with MCA
Paid-up capital
₹3 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Lipotek Pharmaceuticals Private Limited

Data last updated:

Lipotek Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the retail trade segment of the trading and commerce sector. It was incorporated on 17 February 2016 and has been in existence for over 10 years.

The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U51909TN2016PTC104180. Its GSTIN is 33AADCL0190J1ZP (Tamil Nadu).

The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors Ramaswamy Balasubramani and Nagendiran.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.1 Thangalkarai Street Mgr Nagar Chitlapakkam, Chennai, Tamil Nadu, India – 600064.

As per the financials filed for FY 2025, the company reported a revenue of ₹36.8 Lakh, a growth of 26% compared to the previous year. For the same year it recorded a net loss of ₹9,346 (net margin -0.3%) and EBITDA of -₹7,470 (EBITDA margin -0.2%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 11% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U51909TN2016PTC104180
Registration Number 104180
Incorporation Date 17 February 2016
ROC Chennai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Lipotek Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    No.1 Thangalkarai Street Mgr Nagar Chitlapakkam, Chennai, Tamil Nadu, India – 600064
  • Industry
    Trading, Retailers, Retail Trading

To see the full contact details of Lipotek Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Lipotek Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Lipotek Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Lipotek Pharmaceuticals Private Limited, buy the company report.

Financials of Lipotek Pharmaceuticals Private Limited

FY 2025 filings available

Lipotek Pharmaceuticals Private Limited reported revenue of ₹36.8 Lakh (up 26% YoY) for FY 2025.

Revenue · FY 2025
₹36.8 Lakh ▲ 26%
Net loss · FY 2025
₹9,346 margin -0.3%
EBITDA · FY 2025
-₹7,470 margin -0.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 26%
3 years · compounded
▲ 6%
5 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▲ 97%
3 years · compounded
▲ 69%
5 years · compounded
▲ 24%

Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 26% growth in the latest year. EBITDA rose 97% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹7,470
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹9,346
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-0.2%
Net Profit Margin-0.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Lipotek Pharmaceuticals Private Limited, buy the company report.

Board of directors of Lipotek Pharmaceuticals Private Limited

Lipotek Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ramaswamy BalasubramaniDirector17 Feb 201610 Years 8 MonthsCurrent
NagendiranDirector17 Feb 201610 Years 8 MonthsCurrent

Peer comparison

Lipotek Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
BLJ Pharmaceuticals Private Limited₹37.07 Lakh (FY 2025)1530.0%Dadri, Uttar Pradesh, India
Ashi Pharmaceuticals Private Limited₹36.95 Lakh (FY 2019)-11.0%Indore, Madhya Pradesh, India
Lipotek Pharmaceuticals Private Limitedthis company₹36.8 Lakh (FY 2025)-₹9,346-0.3%26.0%Chennai, Tamil Nadu, India
Sun Eye Care Pharmaceuticals Private Limited₹36.68 Lakh (FY 2025)-9.0%Moradabad, Uttar Pradesh, India
Beactive Pharmaceuticals Private Limited₹36.65 Lakh (FY 2024)85.0%Ambala, Haryana, India

To see the full peer comparison of Lipotek Pharmaceuticals Private Limited, buy the company report.

Auditor

Lipotek Pharmaceuticals Private Limited is audited by S.AMMAIAPPAN for the financial year 2017.

Auditor firmFinancial yearFirm registration number
S.AMMAIAPPANFY 2017020396

Shareholding

The shareholding of Lipotek Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Lipotek Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Lipotek Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Lipotek Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
33AADCL0190J1ZPTamil NaduActive01 Jul 2017

To see the full GST registrations and return filing status of Lipotek Pharmaceuticals Private Limited, buy the company report.

Recent activity

Lipotek Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Nagendiran was appointed as Director on 17 Feb 2016.

AGM
Lipotek Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Lipotek Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Appointed
Nagendiran was appointed as Director.
Appointed
Ramaswamy Balasubramani was appointed as Director.
Incorporation
17 Feb 2016
Lipotek Pharmaceuticals Private Limited was registered on 17 Feb 2016 with Roc Chennai & aged 10 years 9 months as per MCA records.

Frequently asked questions

Lipotek Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in retailers, within the trading industry. It was incorporated on 17 February 2016 (10+ years old) and is registered under CIN U51909TN2016PTC104180.

Lipotek Pharmaceuticals has 2 current directors:

The latest financial statements of Lipotek Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.

The GSTIN of Lipotek Pharmaceuticals is 33AADCL0190J1ZP, registered in Tamil Nadu.

The CIN (Corporate Identification Number) of Lipotek Pharmaceuticals is U51909TN2016PTC104180. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Lipotek Pharmaceuticals was incorporated on 17 February 2016, making it 10+ years old. It is registered with the Registrar of Companies, Chennai.

The peers of Lipotek Pharmaceuticals by revenue are BLJ Pharmaceuticals Private Limited, Ashi Pharmaceuticals Private Limited, Sun Eye Care Pharmaceuticals Private Limited, Beactive Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).

Nagendiran was appointed as Director on 17 Feb 2016. Ramaswamy Balasubramani was appointed as Director on 17 Feb 2016.

The registered office of Lipotek Pharmaceuticals is at No.1 Thangalkarai Street Mgr Nagar Chitlapakkam, Chennai, Tamil Nadu, India – 600064.

Lipotek Pharmaceuticals operates in the trading industry, in the retailers segment.

The compliance status of Lipotek Pharmaceuticals is compliant as of 03 September 2026. The company is actively filing with the Registrar of Companies.